Patent Application for Novel Compound Treating Neurodegeneration and Cardiovascular Diseases
Summary
The USPTO has published a patent application (US20260085083A1) for a novel compound and pharmaceutical composition developed by SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD. The compound is intended for preventing or treating neurodegenerative diseases and cardiovascular/cerebrovascular diseases.
What changed
This document is a published patent application from the USPTO for a novel compound and pharmaceutical composition. The application, filed by SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD, details a compound represented by formula (I) that can be used in medicaments for preventing or treating neurodegenerative diseases and cardiovascular and cerebrovascular diseases. The application number is 19113500, and it was filed on September 25, 2023.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in pharmaceutical research and development. Companies operating in the pharmaceutical and biotechnology sectors should monitor the progress of this patent application and related research for insights into emerging treatments and potential intellectual property considerations.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
Application US20260085083A1 Kind: A1 Mar 26, 2026
Assignee
SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD
Inventors
Zhefeng ZHANG, Yuelei MENG
Abstract
A novel compound, a pharmaceutical composition thereof, and use thereof. The novel compound is represented by formula (I), wherein the details of the definition of each substituent group are shown in the specification. The compound can be used for preparing a medicament for preventing or treating a neurodegeneration disease and a cardiovascular and cerebrovascular disease.
CPC Classifications
C07F 9/6561 A61K 31/235 A61K 31/265 A61K 31/4155 A61K 31/4965 A61K 31/4985 A61K 31/675 A61P 9/00 A61P 25/28 C07B 59/002 C07C 69/76 C07C 69/96 C07D 241/12 C07D 241/24 C07D 405/04 C07D 491/048
Filing Date
2023-09-25
Application No.
19113500
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.